Bio-Gene Technology Limited appointed Christopher Mark Ramsey as director, effective 12 May 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.063 AUD | -.--% | -.--% | +5.00% |
Feb. 25 | Bio-Gene Technology Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Jan. 19 | Bio-gene Technology Secures R&D Tax Rebate for Fiscal Year 2023 | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.00% | 8.42M | |
+16.74% | 38.99B | |
-.--% | 11.36B | |
-3.33% | 7.61B | |
+1.10% | 6.45B | |
-4.79% | 6.01B | |
-4.50% | 5.73B | |
+32.88% | 5.25B | |
-16.30% | 5.23B | |
-13.40% | 4.58B |
- Stock Market
- Equities
- BGT Stock
- News Bio-Gene Technology Limited
- Bio-Gene Technology Limited Appoints Christopher Mark Ramsey as Director